Omnicell (OMCL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Stan Berenshteyn from ...

A month has gone by since the last earnings report for Omnicell (OMCL). Shares have lost about 0.4% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...

Omnicell (NASDAQ:OMCL) priced $150 million principal amount of 1.00% convertible senior notes due 2029, with an option to buy an additional $22.5 million for underwriters. Omnicell plans to raise ...

Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced OmniSphere, a next-generation, cloud ...

FORT WORTH, Texas, December 09, 2024--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy and nursing care delivery model ...

FORT WORTH, Texas--(BUSINESS WIRE)-- Omnicell, Inc. (NASDAQ: OMCL) (“Omnicell”) today announced the pricing of $150.0 million aggregate principal amount of 1.00% Convertible Senior Notes due 2 ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in ...

Over the last 30 days, one estimate has moved higher for Omnicell compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 18.57%. Current-Year Estimate Revisions ...